What is ELMD's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.23B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ELMD?

P/E (TTM) is 20.39 and 52-week range is $23.01 to $47.40 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ELMD figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ELMD?

The company profile lists revenue (TTM) near $70M, net income (TTM) near $11M, EPS (TTM) near $1.30 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Electromed Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in New Prague, Minnesota, US, 8.3M shares outstanding, ISIN US2854091087 when available from company profile and filing metadata.

Electromed Inc

$ELMD

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$27.69

-0.40%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The company is headquartered in New Prague, Minnesota and currently employs 177 full-time employees. The company went IPO on 2010-08-13. The company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. The company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.

Employees

179

Website

smartvest.com/

IPO

2010-08-13

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)